Goldman Sachs’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $485M | Sell |
5,600,590
-270,158
| -5% | -$25.9M | 0.06% | 357 |
|
|
2025
Q4 | $564M | Sell |
5,870,748
-2,293,972
| -28% | -$223M | 0.07% | 270 |
|
|
2025
Q3 | $778M | Sell |
8,164,720
-9,478,081
| -54% | -$871M | 0.1% | 190 |
|
|
2025
Q2 | $1.54B | Buy |
17,642,801
+10,812,648
| +158% | +$917M | 0.21% | 73 |
|
|
2025
Q1 | $614M | Buy |
6,830,153
+712,727
| +12% | +$63.8M | 0.1% | 195 |
|
|
2024
Q4 | $489M | Sell |
6,117,426
-523,851
| -8% | -$45.3M | 0.08% | 236 |
|
|
2024
Q3 | $598M | Sell |
6,641,277
-910,864
| -12% | -$76.6M | 0.1% | 202 |
|
|
2024
Q2 | $594M | Buy |
7,552,141
+607,574
| +9% | +$49.8M | 0.1% | 193 |
|
|
2024
Q1 | $605M | Buy |
6,944,567
+941,314
| +16% | +$80.3M | 0.11% | 185 |
|
|
2023
Q4 | $495M | Sell |
6,003,253
-432,451
| -7% | -$33M | 0.09% | 213 |
|
|
2023
Q3 | $504M | Buy |
6,435,704
+319,385
| +5% | +$26.7M | 0.11% | 171 |
|
|
2023
Q2 | $539M | Sell |
6,116,319
-726,805
| -11% | -$62.6M | 0.12% | 156 |
|
|
2023
Q1 | $552M | Buy |
6,843,124
+541,888
| +9% | +$44.2M | 0.13% | 147 |
|
|
2022
Q4 | $490M | Sell |
6,301,236
-2,444,418
| -28% | -$198M | 0.12% | 162 |
|
|
2022
Q3 | $706M | Buy |
8,745,654
+2,162,357
| +33% | +$194M | 0.18% | 96 |
|
|
2022
Q2 | $591M | Sell |
6,583,297
-832,162
| -11% | -$84.3M | 0.15% | 110 |
|
|
2022
Q1 | $823M | Buy |
7,415,459
+1,441,512
| +24% | +$152M | 0.17% | 91 |
|
|
2021
Q4 | $618M | Sell |
5,973,947
-1,892,229
| -24% | -$219M | 0.12% | 147 |
|
|
2021
Q3 | $986M | Buy |
7,866,176
+970,393
| +14% | +$126M | 0.21% | 66 |
|
|
2021
Q2 | $856M | Buy |
6,895,783
+372,719
| +6% | +$46.8M | 0.19% | 78 |
|
|
2021
Q1 | $771M | Buy |
6,523,064
+1,178,874
| +22% | +$138M | 0.19% | 77 |
|
|
2020
Q4 | $626M | Buy |
5,344,190
+849,170
| +19% | +$93.5M | 0.16% | 108 |
|
|
2020
Q3 | $467M | Sell |
4,495,020
-943,253
| -17% | -$94.7M | 0.13% | 137 |
|
|
2020
Q2 | $499M | Sell |
5,438,273
-541,860
| -9% | -$52M | 0.15% | 120 |
|
|
2020
Q1 | $539M | Sell |
5,980,133
-2,098,977
| -26% | -$223M | 0.19% | 93 |
|
|
2019
Q4 | $917M | Buy |
8,079,110
+953,804
| +13% | +$105M | 0.23% | 77 |
|
|
2019
Q3 | $774M | Buy |
7,125,306
+1,042,517
| +17% | +$109M | 0.22% | 78 |
|
|
2019
Q2 | $592M | Sell |
6,082,789
-1,408,389
| -19% | -$129M | 0.17% | 101 |
|
|
2019
Q1 | $682M | Sell |
7,491,178
-1,111,745
| -13% | -$99.5M | 0.21% | 85 |
|
|
2018
Q4 | $783M | Sell |
8,602,923
-529,471
| -6% | -$49.5M | 0.25% | 62 |
|
|
2018
Q3 | $898M | Buy |
9,132,394
+368,035
| +4% | +$34M | 0.23% | 66 |
|
|
2018
Q2 | $750M | Sell |
8,764,359
-3,309,637
| -27% | -$276M | 0.2% | 74 |
|
|
2018
Q1 | $969M | Buy |
12,073,996
+2,998,135
| +33% | +$247M | 0.25% | 63 |
|
|
2017
Q4 | $733M | Buy |
9,075,861
+2,265,494
| +33% | +$181M | 0.18% | 96 |
|
|
2017
Q3 | $530M | Buy |
6,810,367
+677,657
| +11% | +$56.3M | 0.13% | 136 |
|
|
2017
Q2 | $544M | Buy |
6,132,710
+1,440,845
| +31% | +$121M | 0.14% | 118 |
|
|
2017
Q1 | $378M | Buy |
4,691,865
+560,726
| +14% | +$43.8M | 0.1% | 177 |
|
|
2016
Q4 | $294M | Buy |
4,131,139
+531,683
| +15% | +$41.8M | 0.08% | 233 |
|
|
2016
Q3 | $311M | Sell |
3,599,456
-1,565,343
| -30% | -$136M | 0.09% | 196 |
|
|
2016
Q2 | $448M | Sell |
5,164,799
-93,910
| -2% | -$7.59M | 0.15% | 105 |
|
|
2016
Q1 | $394M | Sell |
5,258,709
-1,161,737
| -18% | -$87.5M | 0.13% | 135 |
|
|
2015
Q4 | $494M | Buy |
6,420,446
+1,051,268
| +20% | +$79.1M | 0.16% | 113 |
|
|
2015
Q3 | $359M | Buy |
5,369,178
+382,721
| +8% | +$28.2M | 0.12% | 153 |
|
|
2015
Q2 | $369M | Sell |
4,986,457
-723,596
| -13% | -$55.3M | 0.11% | 175 |
|
|
2015
Q1 | $445M | Buy |
5,710,053
+295,435
| +5% | +$22.4M | 0.14% | 134 |
|
|
2014
Q4 | $391M | Sell |
5,414,618
-140,094
| -3% | -$9.73M | 0.12% | 155 |
|
|
2014
Q3 | $344M | Sell |
5,554,712
-859,253
| -13% | -$54.6M | 0.11% | 172 |
|
|
2014
Q2 | $409M | Sell |
6,413,965
-509,099
| -7% | -$30.9M | 0.13% | 148 |
|
|
2014
Q1 | $426M | Buy |
6,923,064
+2,473,705
| +56% | +$144M | 0.14% | 131 |
|
|
2013
Q4 | $255M | Buy |
4,449,359
+827,185
| +23% | +$46.9M | 0.08% | 251 |
|
|
2013
Q3 | $193M | Sell |
3,622,174
-142,956
| -4% | -$7.69M | 0.07% | 305 |
|
|
2013
Q2 | $194M | Buy |
+3,765,130
| New | +$186M | 0.07% | 287 |
|
Other funds holding MDT
VCM
VPM
Goldman Sachs's MDT Position: Q1 2026 in Review
Goldman Sachs reduced its Medtronic (MDT) stake by 4.6% in Q1 2026, selling an estimated $25.9M and leaving 5,600,590 shares worth $485M. The position accounts for 0.06% of the portfolio, ranked #357.
Goldman Sachs first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.54B in Q2 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Goldman Sachs held 5,600,590 shares of Medtronic worth $485M as of Q1 2026.
- Goldman Sachs sold 270,158 Medtronic shares in Q1 2026, an estimated $25.9M.
- Medtronic made up 0.06% of Goldman Sachs's portfolio in Q1 2026, its #357 holding.
- Goldman Sachs first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Medtronic position peaked at $1.54B in Q2 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.